Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,285,030
-$15,754,602 QoQ
Shares Held
44,215
-79.0% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,532,353,094 across 31 Diagnostics & Research names. GRAL ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,315,471 | $3,104,243,460 | |
| 2 | DHR |
Danaher Corp /De/
|
15,352,887 | $2,910,907,374 | |
| 3 | NTRA |
Natera, Inc.
|
12,184,876 | $2,436,853,350 | |
| 4 | DGX |
Quest Diagnostics Inc
|
6,297,987 | $1,234,279,491 | |
| 5 | RVTY |
Revvity, Inc.
|
10,090,158 | $883,998,742 | |
| 6 | GH |
Guardant Health, Inc.
|
7,023,689 | $648,778,152 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
305,763 | $385,628,295 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
638,063 | $358,521,218 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,285,030 | 44,215 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,039,632 | 210,768 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,874,421 | 31,700 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,513,033 | 29,425 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $648,869 | 25,406 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $437,682 | 24,520 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $277,140 | 20,141 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $294,166 | 19,139 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||